Pliant Therapeutics Receives FDA Fast Track Designation for PLN-74809 for the Treatment of Primary Sclerosing Cholangitis

General
1

Pliant Therapeutics Receives FDA Fast Track Designation for PLN-74809 for the Treatment of Primary Sclerosing Cholangitis

Havent seen anyone post about this yet so figured i would send the link out.

https://www.globenewswire.com/en/news-release/2022/07/21/2483580/0/en/Pliant-Therapeutics-Receives-FDA-Fast-Track-Designation-for-PLN-74809-for-the-Treatment-of-Primary-Sclerosing-Cholangitis.html

2 Likes
2

Thanks for sharing this article “GlasshalfFULL”. It does sound promising. We’ll keep looking out for what comes from the clinical trial studies.

Mark

3

Is there any information on the impact the drug has had in studies conducted so far? How do they define “treatment”?

4

There are a lot of people who hope that works well.